Cytochrome P450 2C9 — Drug Target

All drugs that target Cytochrome P450 2C9 — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

benzbromarone · Cytochrome P450 3A Inhibitor [EPC]

Marketed (2)

• Azubromaron · benzbromarone · Immunology
• Norvir · AbbVie · Cytochrome P450 3A Inhibitor [EPC] · Oncology
  Norvir works by blocking the cytochrome P450 3A enzyme, which helps increase the levels of other medications in the body.